KeyCorp Analysts Increase Earnings Estimates for Clorox Co (CLX)

Clorox Co (NYSE:CLX) – KeyCorp lifted their Q3 2018 earnings estimates for Clorox in a research report issued to clients and investors on Sunday, Zacks Investment Research reports. KeyCorp analyst J. Gere now expects that the company will earn $1.29 per share for the quarter, up from their previous forecast of $1.24. KeyCorp also issued estimates for Clorox’s FY2018 earnings at $6.17 EPS and FY2019 earnings at $6.60 EPS.

Several other brokerages also recently issued reports on CLX. Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating in a report on Monday, November 6th. Morgan Stanley cut their price target on shares of Clorox from $138.00 to $128.00 and set an “equal weight” rating for the company in a report on Thursday, November 2nd. Consumer Edge raised shares of Clorox from a “neutral” rating to an “outperform” rating in a report on Friday, November 10th. Jefferies Group reissued a “hold” rating and set a $132.00 price target on shares of Clorox in a report on Wednesday, November 1st. Finally, Argus downgraded shares of Clorox from a “buy” rating to a “hold” rating and cut their price target for the company from $150.40 to $127.81 in a report on Thursday, February 8th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the company. Clorox presently has an average rating of “Hold” and an average target price of $132.46.

Shares of Clorox (CLX) traded up $1.60 during mid-day trading on Wednesday, reaching $130.40. 453,485 shares of the company traded hands, compared to its average volume of 1,213,186. Clorox has a 12-month low of $124.09 and a 12-month high of $150.40. The company has a market cap of $16,632.30, a P/E ratio of 21.47, a P/E/G ratio of 2.41 and a beta of 0.31. The company has a quick ratio of 0.86, a current ratio of 1.22 and a debt-to-equity ratio of 2.35.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Friday, February 2nd. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.01. Clorox had a net margin of 13.21% and a return on equity of 126.70%. The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same period last year, the firm posted $1.14 EPS. The firm’s quarterly revenue was up .7% on a year-over-year basis.

Several large investors have recently modified their holdings of CLX. Two Sigma Advisers LP grew its position in shares of Clorox by 331.4% during the 4th quarter. Two Sigma Advisers LP now owns 815,434 shares of the company’s stock worth $121,288,000 after buying an additional 626,426 shares during the period. APG Asset Management N.V. grew its holdings in Clorox by 38.6% during the fourth quarter. APG Asset Management N.V. now owns 1,804,215 shares of the company’s stock valued at $223,483,000 after purchasing an additional 502,300 shares during the period. Renaissance Technologies LLC grew its holdings in Clorox by 15.1% during the fourth quarter. Renaissance Technologies LLC now owns 2,360,600 shares of the company’s stock valued at $351,116,000 after purchasing an additional 310,000 shares during the period. Schroder Investment Management Group grew its holdings in Clorox by 197.4% during the fourth quarter. Schroder Investment Management Group now owns 461,861 shares of the company’s stock valued at $68,697,000 after purchasing an additional 306,557 shares during the period. Finally, Amundi Pioneer Asset Management Inc. grew its holdings in Clorox by 196.0% during the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 430,313 shares of the company’s stock valued at $64,005,000 after purchasing an additional 284,937 shares during the period. Institutional investors own 73.42% of the company’s stock.

In other news, SVP Michael R. Costello sold 10,574 shares of Clorox stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the completion of the sale, the senior vice president now owns 34,867 shares in the company, valued at approximately $4,742,260.67. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 1.00% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “KeyCorp Analysts Increase Earnings Estimates for Clorox Co (CLX)” was first posted by Week Herald and is the property of of Week Herald. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://weekherald.com/2018/02/15/clorox-co-to-post-q3-2018-earnings-of-1-29-per-share-keycorp-forecasts-clx.html.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Get a free copy of the Zacks research report on Clorox (CLX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply